• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Veramyst, (fluticasone furoate) Nasal Spray

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2011

 

Summary View

WARNINGS AND PRECAUTIONS

Local Nasal Effects
  • section added

 

ADVERSE REACTIONS

Postmarketing Experience

Respiratory, Thoracic, and Mediastinal Disorders

  • add .... : Rhinalgia, nasal discomfort (including nasal burning, nasal irritation, and nasal soreness), nasal dryness, and nasal septal perforation

 

PATIENT COUNSELING INFORMATION

Keep Spray Out of Eyes
  • section added
Potential Drug Interactions
  • section added